Found 6 matching trials
Combivent® HFA-propelled Compared to CFC-propelled Metered Dose Inhaler in Patients With COPD (Chronic Obstructive Pulmonary Disease)
PHASE2Study to evaluate the safety of combivent delivered in two different formul...
Location
Multiple Locations
Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
PHASE2The purpose of this study is to demonstrate the superior bronchodilator eff...
Location
620 South 20th Street, NHB 104
Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects
PHASE1Study to assess the safety and tolerability of COMBIVENT® hydrofluoroalkane...
Location
Multiple Locations
Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease
PHASE3The primary objective of this study is to evaluate long-term safety and pat...
Location
1012.62.153 Boehringer Ingelheim Investigational Site
Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.
PHASE4The objective of this study is to evaluate the efficacy and safety of 12 we...
Location
205.346.107 Boehringer Ingelheim Investigational Site
Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)
PHASE3The primary objective of this study is to compare the effect of ipratropium...
Location
1012.56.01006 Boehringer Ingelheim Investigational Site